Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase I
IMV Inc. to Present at Upcoming Investor Conference
Phase III
Kodiak Sciences to Host R&D Day on October 14 in San…
Phase I
Roche Vice Chairman Calls for Long-Term Thinking by Business to Save…
Approval
Marizyme Agrees to Distribute Somahlution’s DuraGraft Products in South America and…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
European Results From Global ETNA-AF Registry Show Low Bleeding and Low…
Deals
Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove…
Commercial
AbbVie Stays Busy While Working to Complete Allergan Acquisition
Commercial
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim…
Home
Clinical
Phase III
Phase III
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase III
Kodiak Sciences to Host R&D Day on October 14 in San Francisco to Highlight Recent Clinical Progress and Development Planning for KSI-301
Biospace News
-
October 11, 2019
Phase III
PMZ-1620, an Endothelin-B Agonist, enters Phase III Trial in Patients with Cerebral Ischemic Stroke
Phase III
Polyphor closes the Phase III PRISM studies of murepavadin intravenous formulation and evaluates further product improvement options
Phase III
New England Journal of Medicine Publishes Positive Phase 3 Data for Emgality (galcanezumab-gnlm) in Episodic Cluster Headache
Phase III
ViiV Healthcare Announces Phase III Study Meets Primary Endpoint, Demonstrating the Ability to Control HIV-1 With the 2-drug Regimen Dovato in Virally Suppressed Patients...
Phase III
Biohaven’s Rimegepant Positive Phase 3 Trial For Acute Treatment Of Migraine...
Firstwordpharma News
-
July 10, 2019
0
Phase III
First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy,...
Biospace News
-
July 8, 2019
0
Phase III
MorphoSys’s Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab...
Biospace News
-
July 3, 2019
0
Phase III
Boston Biomedical, Inc. Announces Update on Phase 3 CanStem111P Study of...
Biospace News
-
July 2, 2019
0
Phase III
Teva Presents Positive Results Showing Improvement in Disability and Quality of...
Biospace News
-
July 2, 2019
0
1
2
3
...
22
Page 1 of 22
- Advertisement -
MOST POPULAR
Scottish Medicines Consortium latanoprost + timolol (Fixapost)
May 13, 2019
FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis
May 22, 2019
Lilly Announces Final Exchange Ratio of 4.5121 for Elanco Exchange Offer
March 7, 2019
Atriva Therapeutics Starts Clinical Development of Novel Host-Targeting Antiviral ATR-002 Against...
May 16, 2019
Load more
HOT NEWS
Commercial
Nordic Nanovector ASA: Invitation to First Quarter 2019 Results Presentation and...
Approval
Japan’s Ministry of Health, Labour and Welfare Approves CSL Behring Immunoglobulins...
Neurology
Novartis, Amgen and Banner End Alzheimer’s Program After Analysis Shows Patients’...
Acquisitions
BioNTech to Acquire Antibody Generation Unit of MAB Discovery
